Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-066-4 | CAS number: 604-35-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 05 January 2018 - 23 January 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- The validated in chemico skin sensitization test is the DPRA assay, which is recommended in international guidelines (e.g. OECD) and mentioned in the ECHA guidance as the in chemico test to be performed as part of weight of evidence.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 4 february 2015
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- direct peptide reactivity assay (DPRA)
- Justification for non-LLNA method:
- A validated in chemico skin sensitization test is the DPRA assay, which is recommended in international guidelines (e.g. OECD) and mentioned in the ECHA guidance as one of the non-animal tests to be performed as part of weight of evidence.
Test material
- Reference substance name:
- Cholest-5-en-3-β-yl acetate
- EC Number:
- 210-066-4
- EC Name:
- Cholest-5-en-3-β-yl acetate
- Cas Number:
- 604-35-3
- Molecular formula:
- C29H48O2
- IUPAC Name:
- (1R,3aS,3bS,7S,9aR,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl acetate
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: White crystalline powder
- Storage condition: At room temperature
Constituent 1
In chemico test system
- Details on the study design:
- TEST ITEM PREPERATION
Solubility of the test item in an appropriate solvent was assessed before performing the DPRA. An appropriate solvent dissolved the test item completely, i.e. by visual inspection the solution had to be not cloudy nor have noticeable precipitate. The following solvents were evaluated: acetonitrile (ACN), Milli-Q water (MQ), ACN/MQ (1:1, v/v), isopropanol, acetone/ACN (1:1, v/v) dimethylsulfoxide (DMSO)/ACN (1:9, v/v) and ethanol.
Test item stock solutions were prepared freshly for each reactivity assay. For both the cysteine and lysine reactivity assay 7.65 mg of test item was pre-weighed into a clean amber glass vial and dissolved, just before use, in 1784 µL EtOH after vortex mixing and 1 minute of sonication to obtain a 10 mM# solution. Visual inspection of the forming of a clear solution was considered sufficient to ascertain that the test item was dissolved. The test item, positive control and peptide samples were prepared less than 4 hours before starting the incubation of the cysteine (cys) or lysine (lys) reactivity assay, respectively.
#At a concentration of 100 mM, Cholesteryl acetate was not soluble in any of the solvents tested. At a concentration of 10 mM, the test item was soluble in ethanol (EtOH). Therefore, the Direct Peptide Reactivity Assay (DPRA) study was performed using a 10 mM test item solution prepared in this solvent.
TEST SYSTEM
Synthetic peptides containing cysteine (SPCC) (Ac- RFAACAA-COOH) or synthetic peptides containing lysine (SPCL) (Ac-RFAAKAA-COOH). The molecular weight of SPCC is 750.9 g/mol, and 775.9 g/mol for SPCL. The peptides were stored in the freezer (<-15°C) for a maximum of 6 months.
- Source: JPT Peptide Technologies GmbH, Germany.
- Rationale: Recommended test system in the international OECD guideline for DPRA studies.
- Calibration curve SPCC and SPCL: according to guideline
- Incubation: After preparation, the samples (reference controls, calibration solutions, co-elution control, positive controls and test item samples) were placed in the autosampler, in the dark, and incubated at 25 ± 2.5°C. The incubation time between placement of the samples in the autosampler and analysis of the first RCcysB- or RClysB-sample was 25 hours. The time between the first RCcysB- or RClysB-injection and the last injection of a cysteine or lysine sequence, respectively, did not exceed 30 hours.
Prior to HPLC-PDA analysis the samples were visually inspected for precipitation. The samples that showed precipitation were centrifuged (at 400 g) for 5 minutes at room temperature.
- Analysis: All samples were analyzed according to the HPLC-PDA method presented in Table 1 ('Other information on methods and materials').
The HPLC sequences of the cysteine and lysine reactivity assay for the test item are presented in Table 2 ('Other information on materials and methods').
POSITIVE CONTROL: Cinnamic aldehyde
- Purity: 98.4%
- Batch: MKBP1014V
- Expiry of batch: 31 May 2018
DATA EVALUATION
The concentration of SPCC or SPCL was photometrically determined at 220 nm in each sample by measuring the peak area of the appropriate peaks by peak integration, and by calculating the concentration of peptide using the linear calibration curve derived from the standards.
The Percent Peptide Depletion was determined in each sample by measuring the peak area and dividing it by the mean peak area of the relevant reference controls C according to the following formula:
Percent Peptide Depletion = [1-(Peptide Peak Area in Replicate Injection (at 220 nm)/Mean Peptide Peak Area in Reference Controls (at 220 nm))]*100
In addition, the absorbance at 258 nm was determined in each sample by measuring the peak area of the appropriate peaks by peak integration. The ratio of the 220 nm peak area and the 258 nm peak was used as an indicator of co-elution. For each sample a ratio in the range of 90%< mean area ratio of control samples <110% gives a good indication that co-elution has not occurred.
DATA INTERPRETATION (see Table 3 'Other information on materials and method')
The mean Percent Cysteine Depletion and Percent Lysine Depletion were calculated for the test item. Negative depletion was considered as “0” when calculating the mean. By using the Cysteine 1:10 / Lysine 1:50 prediction model, the threshold of 6.38% average peptide depletion was used to support the discrimination between a skin sensitizer and a non-sensitizer.
Results and discussion
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: Cysteine Reactivity Assay
- Parameter:
- other: SPCC mean percentage
- Value:
- 15.9
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- CV between reference controls: 0.9%
- Positive controls validity:
- valid
- Remarks:
- Mean percentage SPCC: 76.2% ± 1.2%.
- Remarks on result:
- other: SD: 3.4%
- Key result
- Run / experiment:
- other: Lysine Reactivity Assay
- Parameter:
- other: SPCL mean percentage
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- CV between reference controls: 1.6%
- Positive controls validity:
- valid
- Remarks:
- mean percentage SPCL: 53.6% ± 2.3%
- Remarks on result:
- other: SD: 0%
- Other effects / acceptance of results:
- Upon preparation as well as after incubation of the SPCC and SPCL test item samples, a precipitate was observed.
See table 4 and 5 in " any other information on results incl. table" for results and acceptability of DPRA
Any other information on results incl. tables
Table 4: Acceptability of the Direct Peptide Reactivity Assay (DPRA)
|
Cysteine reactivity assay |
Lysine reactivity assay |
||
Acceptability criteria |
Results for SPCC |
Acceptability criteria |
Results for SPCL |
|
Correlation coefficient (r2) standard calibration curve |
>0.99 |
0.997 |
>0.99 |
0.9991 |
Mean peptide concentration RC-A samples (mM) |
0.50 ± 0.05 |
0.502 ± 0.005 |
0.50 ± 0.05 |
0.471 ± 0.013 |
Mean peptide concentration RC-C samples (mM) |
0.50 ± 0.05 |
0.494 ± 0.002 |
0.50 ± 0.05 |
0.469 ± 0.003 |
Mean peptide concentration RC-CEtOHsamples (mM) |
0.50 ± 0.05 |
0.499 ± 0.003 |
0.50 ± 0.05 |
0.458 ± 0.011 |
CV (%) for RC samples B and C |
<15.0 |
0.9 |
<15.0 |
1.6 |
Mean peptide depletion cinnamic aldehyde (%) |
60.8-100 |
76.2 |
40.2-69.0 |
53.6 |
SD of peptide depletion cinnamic aldehyde (%) |
<14.9 |
1.2 |
<11.6 |
2.3 |
SD of peptide depletion for the test item (%) |
<14.9 |
3.4 |
<11.6 |
0.0 |
RC = Reference Control; CV = Coefficient of Variation; SD = Standard Deviation.
Table 5: SPCC and SPCL Depletion, DPRA Prediction and Reactivity Classification for the Test Item
Test item |
SPCC depletion |
SPCL depletion |
Mean of SPCC and SPCL depletion |
DPRA prediction and reactivity classification |
||
Mean |
± SD |
Mean |
± SD |
Cysteine 1:10 / Lysine 1:50 prediction model |
||
Cholesteryl acetate |
15.9% |
±3.4% |
0.0% |
±0.0% |
7.9% |
Positive: Low reactivity |
SD = Standard Deviation.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Study is part of a weight of evidence approach and is not used for classification on its own.
- Conclusions:
- Cholesteryl acetate was positive in the DPRA and was classified in the “low reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Executive summary:
In an in chemico study, performed according to OECD guideline 442C and GLP principles, the reactivity of Cholesteryl acetate towards model synthetic peptides containing either cysteine (SPCC) or lysine (SPCL) was determined to assign the test chemical to one of four reactivity classes used to support the discrimination between skin sensitisers and non skin sensitisers. Following incubation of the test substance with either SPCC or SPCL, the relative peptide concentration was determined by High-Performance Liquid Chromatography (HPLC) with gradient elution and photodiode array (PDA) detection at 220 nm and 258 nm. SPCC and SPCL Percent Depletion Values were calculated and used in the prediction model.
Ethanol was found to be an appropriate solvent to dissolve the test item and was therefore used in this Direct Peptide Reactivity Assay (DPRA) study. Cinnamic aldehyde was used as a positive control. The validation parameters, i.e. calibration curve, mean concentration of Reference Control (RC) samples A and C, the CV for RC samples B and C, the mean percent peptide depletion values for the positive control with its standard deviation value and the standard deviation value of the peptide depletion for the test substance, were within the acceptability criteria for the DPRA assay. Therefore, the study was considered to be valid.
In the cysteine reactivity assay the test item showed 15.9% SPCC depletion while in the lysine reactivity assay the test item showed 0.0% SPCL depletion. The mean of the SPCC and SPCL depletion was 7.9% and as a result the test item was positive in the DPRA and was classified in the “low reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model. Therefore, the test item was considered to be positive in the DPRA. However, since precipitation was observed upon addition of the test item to the SPCC and SPCL peptide solutions, one cannot be sure how much test item remained in the solution to react with the peptides. In addition, the DPRA study was performed using a test item concentration of 10 mM. Consequently, the percentages of SPCC and SPCL depletion might be underestimated.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.